The Ministry of Health, through the Pharmacy and Poisons Board (PPB), has recommended the registration of Lenacapavir, a long ...

At least 1.4 million Kenyans are living with HIV, with approximately 21,009 people estimated to have died from AIDS-related ...

What is Pre-Exposure Prophylaxis (PrEP)? Pre-Exposure Prophylaxis (PrEP) is an HIV prevention strategy that enables HIV-negative people to stay HIV-negative by taking anti-HIV drugs (also called ...

The researchers reviewed major studies of both PrEP for HIV prevention and aspirin for heart attack prevention. They found that both had similar low rates of serious side effects. Aspirin users rarely ...

HIV-1 infection remains a major public health problem, with an estimated 38.4 million people living with HIV and 1.5 million new HIV infections reported worldwide in 2021. The risk of HIV infection ...

CDC: New HIV Pre-Exposure Prophylaxis Guidelines New clinical guidelines on HIV pre-exposure prophylaxis (PrEP) recommend the use of anti-HIV drugs by uninfected patients who are at substantial risk ...

MONTRÉAL, March 25, 2025 /CNW/ - ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (GSK), with Pfizer Inc. and Shionogi as shareholders, is pleased to announce ...

Thiruvananthapuram The death of a 19-year-old college student at Palakkad due to rabies, even after she had been administered the immunoglobulin serum and full vaccination as per schedule, has created ...